04.17.24
On the eve of In-Cosmetics Global, Silab (stand 1J100) invited customers to celebrate its 40th anniversary, report on new research efforts and unveil new products. CEO Brigitte Closs-Gonthier welcomed guests and said that after 40 years, Silab remains focused on natural raw materials, processes built on green chemistry, and cutaneous expertise developed on new models, improved efficacy and safety. The formula has worked for four decades. Silab has annual sales of 62 million euros and spends 20% of revenue on research and innovation. Among its 400 employees, 25% work in R&D. Silab boasts 363 patents and aims to introduce four new actives a year. Observers acknowledge Silab’s prowess—in 2023 the company received five innovation awards.
“We are mastering the processes to offer special products,” Closs-Gonthier told attendees.
Jean-Philippe Cosson, general manager, sales and international subsidiaries, provided details on several of those new products, including Senevisium, which promises to restore the physiological senolysis of fibroblasts. In clinical studies:
• 100% of volunteers said Senevisium made skin 100% firmer, and complexion more uniform and lighter;
• 94% said Senevisium made their complexion more luminous and skin smoother; and
• 83% said their skin had a healthy glow.
During the presentation, several researchers some of their latest work with Silab. Katia Boniface, University of Bordeaux, reviewed the skin’s immune memory response in diseases such as vitiligo. Veronique J Moulin, University of Laval, detailed the benefits of a new immunocompetent and vascularized 3D skin model to better understand cutaneous healing. Finally, Florence Ruggiero, Institute of Functional Genomics of Lyon, explained the benefits of using zebrafish to study immune reaction and regeneration.
“Our vision is that the skin is an ecosystem that includes microbiota, neuro-cutaneous system, immune-cutaneous system and vascular system,” explained Closs-Gonthier. “This approach lets us focus on immunity, a key factor. It impacts regeneration, inflammation, barrier function, senescence and more.”
More info: Silab, https://silab.fr/; Email: silab@silab.fr
“We are mastering the processes to offer special products,” Closs-Gonthier told attendees.
Jean-Philippe Cosson, general manager, sales and international subsidiaries, provided details on several of those new products, including Senevisium, which promises to restore the physiological senolysis of fibroblasts. In clinical studies:
• 100% of volunteers said Senevisium made skin 100% firmer, and complexion more uniform and lighter;
• 94% said Senevisium made their complexion more luminous and skin smoother; and
• 83% said their skin had a healthy glow.
During the presentation, several researchers some of their latest work with Silab. Katia Boniface, University of Bordeaux, reviewed the skin’s immune memory response in diseases such as vitiligo. Veronique J Moulin, University of Laval, detailed the benefits of a new immunocompetent and vascularized 3D skin model to better understand cutaneous healing. Finally, Florence Ruggiero, Institute of Functional Genomics of Lyon, explained the benefits of using zebrafish to study immune reaction and regeneration.
“Our vision is that the skin is an ecosystem that includes microbiota, neuro-cutaneous system, immune-cutaneous system and vascular system,” explained Closs-Gonthier. “This approach lets us focus on immunity, a key factor. It impacts regeneration, inflammation, barrier function, senescence and more.”
More info: Silab, https://silab.fr/; Email: silab@silab.fr